Sport Integrity Australia acknowledges the decision of Union Cycliste Internationale to sanction athlete Julie Barnett for the presence of the metabolite of a prohibited substance and use of a prohibited substance.
Ms Barnett returned an Adverse Analytical Finding (AAF) from an in-competition doping control test at the UCI Masters Track Cycling World Championships on 16 October 2019.
Analysis of her sample detected the presence of Bishydroxy-metabolite (metabolite of LGD-4033).
LGD-4033 is prohibited in and out-of-competition under the S1 Class of Anabolic Agents.
Union Cycliste Internationale imposed a 15-month ban on Ms Barnett commencing 22 November 2019.
She was eligible to return to competition on 22 February 2021.
Additional information on the prohibited substance
LGD-4033, originally developed for the treatment of muscle wasting conditions such as aging, osteoporosis, muscular dystrophy and cancer, is promoted as a selective non-steroidal anabolic agent.
It is claimed to be a substance that induces muscle (and bone) growth without the side effects associated with steroid use. However, information on the safety of LGD-4033 is scarce due to a lack of medium and long-term clinical trials – hence the medium and long-term health impacts are unknown.
It should be noted that a number of SARMs have associated health-risks, particularly for the heart and liver.
Sport Integrity Australia is committed to protecting the right of clean athletes to fair competition. If you are aware of any suspicious doping activity, you can report it anonymously via the Sport Integrity Australia website
